Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
BMC Biochem
PMID: 38980576
4:e6469
Agomelatine (Valdoxan), a synthetic version of the neurohormone melatonin, is approved in Europe as a treatment for depression and has demonstrated anti-anxiety effects
Neuroprotection Emerging Evidence Evidence Rating: Emerging (Interesting animal data, limited scope) Neurological applications show promise but require more research: Dopaminergic system protection Peripheral nerve regeneration Traumatic brain injury Alcohol-related neurological damage The GABAergic system interactions and NO modulation provide mechanistic support, but this area needs more study
US$ 29.96
US$ 28.70
US$ 26.86
